STAB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.406400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.982400E-01
Normal-vs-Stage2
3.425600E-01
Normal-vs-Stage3
2.652600E-01
Normal-vs-Stage4
3.294200E-01
Stage1-vs-Stage2
3.716000E-02
Stage1-vs-Stage3
4.093800E-01
Stage1-vs-Stage4
4.381800E-01
Stage2-vs-Stage3
6.580200E-01
Stage2-vs-Stage4
8.191000E-01
Stage3-vs-Stage4
6.132800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.460000E-01
Normal-vs-AfricanAmerican
3.061200E-01
Normal-vs-Asian
3.027200E-01
Caucasian-vs-AfricanAmerican
7.918100E-02
Caucasian-vs-Asian
4.953800E-02
AfricanAmerican-vs-Asian
8.926800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.241400E-01
Normal-vs-Female
3.636000E-01
Male-vs-Female
8.173900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.125200E-01
Normal-vs-Age(41-60Yrs)
3.644200E-01
Normal-vs-Age(61-80Yrs)
3.291000E-01
Normal-vs-Age(81-100Yrs)
3.600000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.514400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.395000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.513400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.438200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.305400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.405800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.176000E-01
Normal-vs-Daily Drinker
3.343600E-01
Normal-vs-Weekly Drinker
2.758200E-01
Normal-vs-Occasional Drinker
2.984800E-01
Normal-vs-Social Drinker
3.383600E-01
Non Drinker-vs-Daily Drinker
5.671800E-01
Non Drinker-vs-Weekly Drinker
2.600800E-01
Non Drinker-vs-Occasional Drinker
3.828000E-01
Non Drinker-vs-Social Drinker
4.567000E-01
Daily Drinker-vs-Weekly Drinker
3.371600E-01
Daily Drinker-vs-Occasional Drinker
1.765950E-01
Daily Drinker-vs-Social Drinker
8.741000E-01
Weekly Drinker-vs-Occasional Drinker
1.844030E-01
Weekly Drinker-vs-Social Drinker
3.542600E-01
Occasional Drinker-vs-Social Drinker
6.412000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.461800E-01
Normal-vs-Grade 2
5.572600E-01
Normal-vs-Grade 3
5.506000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.956400E-01
Grade 1-vs-Grade 3
6.330200E-01
Grade 1-vs-Grade 4
5.461800E-01
Grade 2-vs-Grade 3
3.881200E-01
Grade 2-vs-Grade 4
5.572600E-01
Grade 3-vs-Grade 4
5.506000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.385800E-01
Normal-vs-NonDiabetic
3.328000E-01
Diabetic-vs-NonDiabetic
7.945000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.204800E-01
Normal-vs-NoPancreatitis
3.357800E-01
Pancreatitis-vs-NoPancreatitis
5.106000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.311200E-01
Normal-vs-N1
3.457400E-01
N0-vs-N1
4.557000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.430400E-01
Normal-vs-TP53-NonMutant
2.797600E-01
TP53-Mutant-vs-TP53-NonMutant
1.572820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
